**Core Concept**
Mild hemophilia A is characterized by a deficiency of factor VIII, an essential clotting factor in the intrinsic coagulation pathway. Patients with mild hemophilia A typically exhibit mild bleeding symptoms, such as easy bruising or prolonged bleeding after surgery.

**Why the Correct Answer is Right**
Desmopressin, also known as DDAVP (1-deamino-8-D-arginine vasopressin), is used to manage mild hemophilia A by increasing factor VIII levels. It works by releasing stored factor VIII from endothelial cells and by stimulating the release of factor VIII from the liver. This results in a temporary increase in factor VIII levels, which can help to control bleeding symptoms. Desmopressin is a synthetic analogue of vasopressin and has a longer duration of action compared to the natural hormone.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because factor IX is deficient in hemophilia B (also known as Christmas disease), not hemophilia A.
**Option B:** This option is incorrect because aminocaproic acid is an antifibrinolytic agent used to treat excessive fibrinolysis, not a deficiency of clotting factors like hemophilia A.
**Option C:** This option is incorrect because factor VII is not directly involved in the intrinsic coagulation pathway, and its deficiency leads to a different bleeding disorder.

**Clinical Pearl / High-Yield Fact**
Desmopressin is also used to manage diabetes insipidus, a condition characterized by excessive thirst and urination due to a deficiency of antidiuretic hormone (ADH). The vasopressin analogue has a longer duration of action and is less likely to cause side effects compared to the natural hormone.

**Correct Answer: D. Desmopressin**